591 related articles for article (PubMed ID: 10975553)
21. Drug resistance-associated factors in primary and secondary glioblastomas and their precursor tumors.
Tews DS; Nissen A; Külgen C; Gaumann AK
J Neurooncol; 2000 Dec; 50(3):227-37. PubMed ID: 11263502
[TBL] [Abstract][Full Text] [Related]
22. Expression of proteins associated with therapy resistance in rhabdomyosarcoma and neuroblastoma tumour cells.
Pituch-Noworolska A; Zaremba M; Wieczorek A
Pol J Pathol; 2009; 60(4):168-73. PubMed ID: 20072950
[TBL] [Abstract][Full Text] [Related]
23. Novel mechanisms of drug resistance in leukemia.
Ross DD
Leukemia; 2000 Mar; 14(3):467-73. PubMed ID: 10720143
[TBL] [Abstract][Full Text] [Related]
24. Multidrug resistance related molecules in human and murine lung.
Scheffer GL; Pijnenborg AC; Smit EF; Müller M; Postma DS; Timens W; van der Valk P; de Vries EG; Scheper RJ
J Clin Pathol; 2002 May; 55(5):332-9. PubMed ID: 11986335
[TBL] [Abstract][Full Text] [Related]
25. Expression of P-glycoprotein, multidrug resistance-associated protein 1, and lung resistance-related protein in human soft tissue sarcomas before and after hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan.
Komdeur R; Plaat BE; Hoekstra HJ; Molenaar WM; Hollema H; van den Berg E; Mastik MF; van der Graaf WT
Cancer; 2001 May; 91(10):1940-8. PubMed ID: 11346877
[TBL] [Abstract][Full Text] [Related]
26. [Correlation of chemosensitivity tested using histoculture drug response assay to expression of multidrug resistance genes and proteins in colorectal cancer tissues].
Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Qiu HB; Zhang LY
Ai Zheng; 2009 Sep; 28(9):932-8. PubMed ID: 19728910
[TBL] [Abstract][Full Text] [Related]
27. ATP-binding cassette efflux transporters and MDR in cancer.
Pote MS; Gacche RN
Drug Discov Today; 2023 May; 28(5):103537. PubMed ID: 36801375
[TBL] [Abstract][Full Text] [Related]
28. ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development.
Choi YH; Yu AM
Curr Pharm Des; 2014; 20(5):793-807. PubMed ID: 23688078
[TBL] [Abstract][Full Text] [Related]
29. Resistance mechanisms associated with altered intracellular distribution of anticancer agents.
Larsen AK; Escargueil AE; Skladanowski A
Pharmacol Ther; 2000 Mar; 85(3):217-29. PubMed ID: 10739876
[TBL] [Abstract][Full Text] [Related]
30. Overcoming Multidrug Resistance: Flavonoid and Terpenoid Nitrogen-Containing Derivatives as ABC Transporter Modulators.
M F Gonçalves B; S P Cardoso D; U Ferreira MJ
Molecules; 2020 Jul; 25(15):. PubMed ID: 32722234
[TBL] [Abstract][Full Text] [Related]
31. Development and characterisation of novel human multidrug resistant mammary carcinoma lines in vitro and in vivo.
Stein U; Walther W; Lemm M; Naundorf H; Fichtner I
Int J Cancer; 1997 Sep; 72(5):885-91. PubMed ID: 9311609
[TBL] [Abstract][Full Text] [Related]
32. Role of ABC transporters in cancer chemotherapy.
Sun YL; Patel A; Kumar P; Chen ZS
Chin J Cancer; 2012 Feb; 31(2):51-7. PubMed ID: 22257384
[TBL] [Abstract][Full Text] [Related]
33. Multidrug resistance in leukemia.
Leith C
Curr Opin Hematol; 1998 Jul; 5(4):287-91. PubMed ID: 9747635
[TBL] [Abstract][Full Text] [Related]
34. P-glycoprotein, lung resistance-related protein and multidrug resistance-associated protein in de novo adult acute lymphoblastic leukaemia.
Damiani D; Michelutti A; Michieli M; Masolini P; Stocchi R; Geromin A; Ermacora A; Russo D; Fanin R; Baccarani M
Br J Haematol; 2002 Mar; 116(3):519-27. PubMed ID: 11849207
[TBL] [Abstract][Full Text] [Related]
35. Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.
Allen JD; van Loevezijn A; Lakhai JM; van der Valk M; van Tellingen O; Reid G; Schellens JH; Koomen GJ; Schinkel AH
Mol Cancer Ther; 2002 Apr; 1(6):417-25. PubMed ID: 12477054
[TBL] [Abstract][Full Text] [Related]
36. Expression of multidrug resistance associated transporters (MDR1, MRP1, LRP and BCRP) in porcine oocyte.
Takebayashi Y; Nakayama K; Fujioka T; Kanzaki A; Mutho M; Uchida T; Miyazaki K; Ito M; Fukumoto M
Int J Mol Med; 2001 Apr; 7(4):397-400. PubMed ID: 11254880
[TBL] [Abstract][Full Text] [Related]
37. Relationship of LRP-human major vault protein to in vitro and clinical resistance to anticancer drugs.
Izquierdo MA; Scheffer GL; Flens MJ; Shoemaker RH; Rome LH; Scheper RJ
Cytotechnology; 1996; 19(3):191-7. PubMed ID: 8862006
[TBL] [Abstract][Full Text] [Related]
38. Establishment and characterization of adriamycin-resistant human colorectal adenocarcinoma HCT-15 cell lines with multidrug resistance.
Uchiyama-Kokubu N; Watanabe T
Anticancer Drugs; 2001 Oct; 12(9):769-79. PubMed ID: 11593059
[TBL] [Abstract][Full Text] [Related]
39. Cyclosporin A is a broad-spectrum multidrug resistance modulator.
Qadir M; O'Loughlin KL; Fricke SM; Williamson NA; Greco WR; Minderman H; Baer MR
Clin Cancer Res; 2005 Mar; 11(6):2320-6. PubMed ID: 15788683
[TBL] [Abstract][Full Text] [Related]
40. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]